INTRECATE Trademark

Trademark Overview


On Friday, October 22, 2021, a trademark application was filed for INTRECATE with the United States Patent and Trademark Office. The USPTO has given the INTRECATE trademark a serial number of 97087466. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Tuesday, September 3, 2024. This trademark is owned by Intrecate Biotherapeutics, Inc.. The INTRECATE trademark is filed in the Pharmaceutical Products category with the following description:

House mark for a full line of pharmaceutical preparations for human use; pharmaceutical preparations for human use for treatment and prevention of inflammatory, oncological, autoimmune, genetic, neurological, metabolic, infectious, hematological, musculo-skeletal, degenerative, cardiovascular, respiratory, gastrointestinal, endocrinological, dermatological, genitourinary, ophthalmological, hepatic, and nephrological diseases and conditions; pharmaceutical preparations for human use for treatment and prevention of pain; pharmaceutical preparations for human use for treatment and prevention of allergies; pharmaceutical preparations for human use, namely, diagnostic preparations for medical purposes; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals
intrecate

General Information


Serial Number97087466
Word MarkINTRECATE
Filing DateFriday, October 22, 2021
Status732 - THIRD EXTENSION - GRANTED
Status DateTuesday, September 3, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 21, 2023

Trademark Statements


Goods and ServicesHouse mark for a full line of pharmaceutical preparations for human use; pharmaceutical preparations for human use for treatment and prevention of inflammatory, oncological, autoimmune, genetic, neurological, metabolic, infectious, hematological, musculo-skeletal, degenerative, cardiovascular, respiratory, gastrointestinal, endocrinological, dermatological, genitourinary, ophthalmological, hepatic, and nephrological diseases and conditions; pharmaceutical preparations for human use for treatment and prevention of pain; pharmaceutical preparations for human use for treatment and prevention of allergies; pharmaceutical preparations for human use, namely, diagnostic preparations for medical purposes; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals
Pseudo MarkINTRICATE

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 8, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameIntrecate Biotherapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 022102600

Party NameIntrecate Biotherapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 022102600

Trademark Events


Event DateEvent Description
Tuesday, August 2, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, October 26, 2021NEW APPLICATION ENTERED
Monday, November 8, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, August 1, 2022ASSIGNED TO EXAMINER
Tuesday, August 2, 2022NON-FINAL ACTION WRITTEN
Tuesday, August 2, 2022NON-FINAL ACTION E-MAILED
Thursday, February 2, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 2, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 2, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 10, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 1, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 21, 2023PUBLISHED FOR OPPOSITION
Tuesday, March 21, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 16, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, August 18, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, August 18, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, August 18, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, August 18, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, November 6, 2023SOU TEAS EXTENSION RECEIVED
Monday, November 6, 2023SOU EXTENSION 1 FILED
Monday, April 22, 2024SOU EXTENSION 2 GRANTED
Monday, November 6, 2023SOU EXTENSION 1 GRANTED
Wednesday, November 8, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 22, 2024SOU TEAS EXTENSION RECEIVED
Monday, April 22, 2024SOU EXTENSION 2 FILED
Tuesday, April 23, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 3, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, September 3, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 3, 2024SOU EXTENSION 3 FILED
Tuesday, September 3, 2024SOU EXTENSION 3 GRANTED